Literature DB >> 12862258

A case report of fatal dapsone-induced agranulocytosis in an Indian mid-borderline leprosy patient.

Ramesh M Bhat1, K Radhakrishnan.   

Abstract

Fatal agranulocytosis in an Indian male receiving 100mg of dapsone daily, hospitalized for mid-borderline leprosy in type I reaction with triple nerve paralysis is reported. Various case reports concerning dapsone-induced agranulocytosis are reviewed.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12862258

Source DB:  PubMed          Journal:  Lepr Rev        ISSN： 0305-7518            Impact factor:   0.537


  3 in total

1.  Dapsone-induced agranulocytosis in patients with Hansen's disease.

Authors:  Tania Rita Moreno de Oliveira Fernandes; Bruno Nascimento de Jesus; Tathyane Trajano Barreto; Anderson de Almeida Pereira
Journal:  An Bras Dermatol       Date:  2017 Nov-Dec       Impact factor: 1.896

Review 2.  Drug-Induced Neutropenia During Treatment of Non-Neoplastic Dermatologic Diseases: A Review.

Authors:  Chang-Yu Hsieh; Tsen-Fang Tsai
Journal:  Clin Drug Investig       Date:  2020-10       Impact factor: 2.859

3.  Adverse reactions in leprosy patients who underwent dapsone multidrug therapy: a retrospective study.

Authors:  Sanjeev Guragain; Namrata Upadhayay; Bishwa Mohan Bhattarai
Journal:  Clin Pharmacol       Date:  2017-06-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.